Two open-label, single arm, non-randomized phase II studies...

BMC Cancer 2019 / 12 Vol. 19; Iss. 1

Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene

Kümler, Iben, Balslev, Eva, Stenvang, Jan, Brünner, Nils, Ejlertsen, Bent, Jakobsen, Erik Hugger, Nielsen, Dorte Lisbet
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-019-5788-9
Date:
December, 2019
File:
PDF, 545 KB
english, 2019
Conversion to is in progress
Conversion to is failed